ASLAN Pharmaceuticals Overview
- Year Founded
-
2010
- Status
-
Out of Business
- Employees
-
35
- Latest Deal Type
-
Liquidation
- Financing Rounds
-
12
- Investments
-
4
ASLAN Pharmaceuticals General Information
Description
Operator of a biopharmaceutical company catering to the healthcare industry. The company specializes in clinical-stage immunology and oncology-focused biopharmaceutical thereby developing treatments to transform the lives of patients.
Contact Information
Website
aslanpharma.comCorporate Office
- 3 Temasek Avenue, Centennial Tower
- Level 18
- Singapore, 039190
- Singapore
Corporate Office
- 3 Temasek Avenue, Centennial Tower
- Level 18
- Singapore, 039190
- Singapore
ASLAN Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
ASLAN Pharmaceuticals Comparisons
Industry
Financing
Details
ASLAN Pharmaceuticals Competitors (9)
One of ASLAN Pharmaceuticals’s 9 competitors is Bristol-Myers Squibb, a Corporation company based in Princeton, NJ.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Bristol-Myers Squibb | Corporation | Princeton, NJ | ||||
| Novartis | Corporation | Basel, Switzerland | ||||
| BioAtla | Formerly VC-backed | San Diego, CA | ||||
| BeOne Medicines | Formerly PE-Backed | Beijing, China | ||||
| AbbVie | Corporation | North Chicago, IL |
ASLAN Pharmaceuticals Patents
ASLAN Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025095864-A1 | Treatment | Inactive | 02-Nov-2023 | ||
| WO-2024054157-A1 | Treatment for sleep loss or sleep disturbance in patients with dermatitis | Inactive | 06-Sep-2022 | ||
| US-20260232585-A1 | High concentration anti-il13r antibody formulation | Pending | 26-Aug-2022 | ||
| WO-2024043837-A1 | High concentration anti-il13r antibody formulation | Inactive | 26-Aug-2022 | ||
| GB-202208572-D0 | Dhodh inhibitor polymorph | Inactive | 13-Jun-2022 |
ASLAN Pharmaceuticals Signals
ASLAN Pharmaceuticals Investments (4)
ASLAN Pharmaceuticals’s most recent deal was a Joint Venture with Jaguahr Therapeutics. The deal was made on 15-Oct-2019.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Jaguahr Therapeutics | 15-Oct-2019 | Joint Venture | Drug Discovery | ||
| CSL (Atopic Dermatitis Candidate ASLAN004) | 31-May-2019 | Corporate Asset Purchase | Buildings and Property | ||
| DotBio | 12-Apr-2019 | Early Stage VC | Drug Discovery | ||
| Array BioPharma (Varlitinib) | 03-Jan-2018 | Corporate Asset Purchase | Buildings and Property |
ASLAN Pharmaceuticals FAQs
-
When was ASLAN Pharmaceuticals founded?
ASLAN Pharmaceuticals was founded in 2010.
-
Where is ASLAN Pharmaceuticals headquartered?
ASLAN Pharmaceuticals is headquartered in Singapore, Singapore.
-
What is the size of ASLAN Pharmaceuticals?
ASLAN Pharmaceuticals has 35 total employees.
-
What industry is ASLAN Pharmaceuticals in?
ASLAN Pharmaceuticals’s primary industry is Drug Discovery.
-
Is ASLAN Pharmaceuticals a private or public company?
ASLAN Pharmaceuticals is a Private company.
-
What is ASLAN Pharmaceuticals’s current revenue?
The current revenue for ASLAN Pharmaceuticals is .
-
How much funding has ASLAN Pharmaceuticals raised over time?
ASLAN Pharmaceuticals has raised $277M.
-
Who are ASLAN Pharmaceuticals’s competitors?
Bristol-Myers Squibb, Novartis, BioAtla, BeOne Medicines, and AbbVie are some of the 9 competitors of ASLAN Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process